Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer

The underlying molecular mechanisms of resistance to cisplatin-based systemic chemotherapy in bladder cancer patients remain to be elucidated, while the link between androgen receptor (AR) activity and chemosensitivity in urothelial cancer has been implicated. Our DNA microarray analysis in control...

Descripción completa

Detalles Bibliográficos
Autores principales: Teramoto, Yuki, Jiang, Guiyang, Goto, Takuro, Mizushima, Taichi, Nagata, Yujiro, Netto, George J., Miyamoto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466436/
https://www.ncbi.nlm.nih.gov/pubmed/34576193
http://dx.doi.org/10.3390/ijms221810030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466436/
https://www.ncbi.nlm.nih.gov/pubmed/34576193
http://dx.doi.org/10.3390/ijms221810030

Ejemplares similares